Morphine Sulfate Injection Recalled Due to Lack of Sterility Assurance
Nephron Sterile Compounding Center LLC is recalling Morphine Sulfate Injection due to lack of assurance of sterility. The recall affects 8,985 syringes distributed nationwide.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: The recall involves a Class II drug with a lack of sterility assurance on injectable medication. No illnesses or injuries have been reported. This falls under 'risk-of-harm products where injury has not yet been reported,' per the severity rubric.
Plain-English summary
Nephron Sterile Compounding Center LLC is recalling Morphine Sulfate Injection, USP, 30 mg/30 mL (1 mg/mL), packaged in pre-filled syringes. The recall was initiated due to lack of assurance of sterility.
The recall affects approximately 8,985 syringes distributed nationwide in the USA across six lot numbers: MS2004A (expiration 7/30/2022), MS2007A (expiration 8/23/2022), MS2012A (expiration 9/6/2022), MS2014A (expiration 9/10/2022), MS2016A (expiration 9/29/2022), and MS2018A (expiration 10/12/2022). The product NDC is 69374-979-30. Morphine Sulfate Injection is a prescription-only medication.
Patients and healthcare providers who received affected lots should discontinue use immediately and consult with their pharmacy or healthcare provider. Do not use the medication. For product disposal or additional information, contact Nephron Sterile Compounding Center LLC at 4500 12th St. Extension, West Columbia, SC 29172, or refer to FDA recall number D-1266-2022.
The recalled product
- Product
- Morphine Sulfate Injection, USP, 30 mg/30 mL (1 mg/mL) syringe, packaged in 5 x 30 mL Pre-Filled Syringes per carton, 6 x 5 Syringe Carton per case, Rx Only, Nephron 503B outsourcing facility, 4500 12th St. Extension, West Columbia, SC 29172, NDC: 69374-979-30
- Manufacturer
- Nephron Sterile Compounding Center LLC
- Category
- Drug — Injectable Opioid
- Affected units
- 8,985
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (12)
- Lots: MS2004A
- Exp. 7/30/2022
- MS2007A
- Exp. 8/23/2022
- MS2012A
- Exp. 9/6/2022
- MS2014A
- Exp. 9/10/2022
- MS2016A
- Exp. 9/29/2022
- MS2018A
- Exp. 10/12/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 37 recalled by Nephron Sterile Compounding Center LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 37 products in this recall →Related recalls
Same manufacturer · Nephron Sterile Compounding Center LLC
See all →- HighSodium Chloride Injection Recalled for Potential Sterility Compromise
FDA (Drugs) · 2025-03-19
- HighNorepinephrine Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighNephron Phenylephrine HCl Injection Recalled for Sterility Assurance
FDA (Drugs) · 2023-03-08
- HighDiltiazem HCl Injectable Drug Recalled for Sterility Assurance Failure
FDA (Drugs) · 2023-03-08
- HighFDA Recalls Norepinephrine Injection Due to Sterility Concerns
FDA (Drugs) · 2023-03-08
Same hazard · sterility assurance
See all →- HighArrowhead DE LLC Recalls Arrow-LOK Implants Due to Sterility Assurance Concerns
FDA (Devices) · 2026-08-26
- SevereChloraPrep One-Step Applicators Recalled for Potential Packaging Seal Defects
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15
- SevereChloraPrep One-Step Applicators Recalled Due to Sterility Assurance Failure
FDA (Drugs) · 2026-07-08
- SevereArrow drainage and thoracentesis kits contain recalled supplier drugs
FDA (Devices) · 2026-06-24